New research has revealed that peoples’ personality types predicts their donations to charities and noble causes.

In a sample of almost 1000 participants the researchers found that people with a pro-social personality gave more money to charities and other noble causes.

The saying goes that "time flies when you're having fun" and accident victims report events happening in slow motion as disaster occurred. But can humans really experience events at different speeds? Is time that relative?

Apparently not, said researchers at Baylor College of Medicine in Houston, who studied how volunteers experience time when they free-fall 100 feet into a net below. Even though participants remembered their own falls as having taken one-third longer than those of the other study participants, they were not able to see more events in time.

Instead, the longer duration was a trick of their memory, not an actual slow-motion experience.

“People commonly report that time seemed to move in slow motion during a car accident,” said Dr.

AMSTERDAM, the Netherlands, December 12 /PRNewswire/ --

- Forty-five Prestigious Journals to be Launched on ScienceDirect in Response to Customer Demand

Elsevier, a leading publisher of scientific, technical and medical (STM) information, today announced that 45 French-language medical journals from Elsevier Masson will be available on ScienceDirect beginning January 3, 2008.

ZUG, Switzerland, December 12 /PRNewswire/ -- Swiss Hawk AG's portfolio company Vitaboost International BV launches its new website with online shop today. The new online shop enables customers from all over Europe to order Vitaboost products online. In addition, Vitaboost products will be available in stores from Friday 14th December. The first Vitaboost product is the "Vitaboost Activator", a healthy energy drink product for everyday use with a base of orange, grape and lime juice enriched with Ginkgo Biloba, Taurin, Ginseng, Vitamin B Complex, Vitamin C, Caffeine, Schisandra and Guarana. Check out http://www.vitaboost.com for more information.

About Vitaboost International BV

FRIMLEY, England, December 12 /PRNewswire/ --

- Approximately 78% of Beta-thalassaemia Patients had Decreases in Cardiac Iron and 90% had Decreases in Liver Iron After Six Months, Interim Data Show(1)

- Study in Sickle Cell Disease (SCD) Patients With Iron Overload Showed Continued Safety and Efficacy Over Two Years(2)

- Safety and Efficacy Demonstrated in Lower-Risk Myelodysplastic Syndromes (MDS) Patients(3)

COPENHAGEN, December 12 /PRNewswire/ --

- Summary: An IND has Been Filed With the FDA for the Fourth Genmab Antibody Developed Under the Company's Collaboration With Roche.

Genmab A/S (OMX: GEN) announced today that an Investigational New Drug application (IND) for a Genmab antibody developed under the company's collaboration with Roche has been filed with the FDA by Roche. Genentech and Roche are collaborating on development of the antibody which selectively blocks the interaction of the OX40 ligand and its receptor. The companies are evaluating the antibody for the treatment of asthma. Genmab will receive a milestone payment from Roche which does not influence Genmab's financial guidance for 2007.

LONDON, December 12 /PRNewswire/ -- PRNewswire, London, December 12 - Mippin makes it easy to find, read and share content from the most popular news and blogs using your mobile internet browser. The service provides quick access to what other people are reading most during the day and with Christmas around the corner, the new Mippin Gift Guide makes it simple to see what's happening this season. Just point your phone's web browser to: http://mippin.com/giftguide to find mobile phone reviews and other gift inspirations right on your mobile phone. See PRNewswire story 1 FEATURE: Mobile Top 10 on the wire or visit http://www.mediapoint.press.net or http://www.prnewswire.co.uk.

ATTN: FEATURES EDITORS

- With Photo

BRUSSELS, Belgium, December 12 /PRNewswire/ --

The Crossroads Institute for medical education today announced it will develop new educational programs for healthcare professionals focused on improving the treatment of women with cardiovascular disease and the prevention of amputation. The announcement was made by the newly formed committee of the Crossroads Educational Research Program (CERP) at the Crossroads Institute in Brussels, Belgium, which is focused on providing the latest in medical education to advance the treatment of patients with cardiac and vascular disease and is supported by an educational grant from Abbott Vascular.

DALLAS, December 12 /PRNewswire/ --

- Kingdom sought trusted vendor for national ID project, e-government rollout to protect 27 million citizens

The remains of one of the largest meat-eating dinosaurs ever found have recently been recognized as representing a new species by a student working at the University of Bristol.

The new species is one of the largest carnivorous dinosaurs ever to have lived. Carcharodontosaurus iguidensis was probably 13-14 metres long, making it taller than a double-decker bus. It had a skull about 1.75 metres long and its teeth were the size of bananas.

Steve Brusatte, an MSc student the University of Bristol who identified the theropod said: “The first remains of Carcharodontosaurus were found in the 1920s, but they only consisted of two teeth which have since been lost.